AU2003303055A1 - Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum - Google Patents

Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum

Info

Publication number
AU2003303055A1
AU2003303055A1 AU2003303055A AU2003303055A AU2003303055A1 AU 2003303055 A1 AU2003303055 A1 AU 2003303055A1 AU 2003303055 A AU2003303055 A AU 2003303055A AU 2003303055 A AU2003303055 A AU 2003303055A AU 2003303055 A1 AU2003303055 A1 AU 2003303055A1
Authority
AU
Australia
Prior art keywords
proteins
outer membrane
vaccine against
subunit vaccine
salmonella gallinarum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303055A
Inventor
Khalid Bouzoubaa
Mohammed Omar El Amrani El Mrini
Medhi El Harrak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROBIOTECH SARL
Original Assignee
PROBIOTECH SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROBIOTECH SARL filed Critical PROBIOTECH SARL
Publication of AU2003303055A1 publication Critical patent/AU2003303055A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003303055A 2002-12-04 2003-01-17 Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum Abandoned AU2003303055A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MA26934 2002-12-04
MA26934A MA26911A1 (en) 2002-12-04 2002-12-04 UNITARY VACCINE AGAINST AVIAN TYPHOSIS PRODUCED FROM PROTEINS FROM THE EXTERNAL MEMBRANE OF SALMONELLA GALLINARUM. "
PCT/MA2003/000001 WO2004054612A1 (en) 2002-12-04 2003-01-17 Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum

Publications (1)

Publication Number Publication Date
AU2003303055A1 true AU2003303055A1 (en) 2004-07-09

Family

ID=32589018

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303055A Abandoned AU2003303055A1 (en) 2002-12-04 2003-01-17 Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum

Country Status (4)

Country Link
EP (1) EP1572232A1 (en)
AU (1) AU2003303055A1 (en)
MA (1) MA26911A1 (en)
WO (1) WO2004054612A1 (en)

Also Published As

Publication number Publication date
EP1572232A1 (en) 2005-09-14
MA26911A1 (en) 2004-12-20
WO2004054612A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2002331258A1 (en) Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
AU2002226818A1 (en) Ultrasonic imaging of perfusion using gases with different partial pressures
MXPA03007323A (en) Artificial proteins with reduced immunogenicity.
IL173726A0 (en) N,n-dihalogenated amino acids and derivatives
AU2003237802A1 (en) Localization element with energized tip
GB0419627D0 (en) Immunogenic bacterial vesicles with outer membrane proteins
AU2002353921A1 (en) Proteins stabilized with polysaccharide gums
AU2003209059A1 (en) Human monoclonal antibodies against membrane proteins
NO20052807D0 (en) Process for the preparation of amino acids
EP1511846A4 (en) Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
AU2003295843A1 (en) Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same
AU2003235577A1 (en) Identification of small ruminants
AU2003303055A1 (en) Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum
AU2003288558A1 (en) Meningococcal vaccine based on outer membrane proteins porb2 and pora
AU2003302234A1 (en) Immune response associated proteins
AU2003209648A1 (en) Subunits of the adenovirus fiber protein and uses thereof as vaccines
ATE394424T1 (en) PREPARATION OF SOMATOSTATIN PEPTIDES
BR0116646B1 (en) improvement of plaster integrity by replacing the constructive adhesive with ultrasonic compressions.
TW200517120A (en) Protein from Photobacterium damselae and use thereof
AU2003238178A1 (en) Pancreas-specific proteins
ITTO20010237A0 (en) PROCEDURE FOR THE PREPARATION OF A PROTEIN HYDROLYZATE USEFUL FOR USE AS A FERTILIZER.
DE60131170D1 (en) Artificial lung of the membrane type
AU2003213167A1 (en) Sequence analysis of the tetravalent rotavirus vaccine
FI20020868A (en) Pressure vessels
IT1338456B1 (en) PROCEDURE FOR THE PREPARATION OF ALCHILUREE DA O, D-DIMETHYL DICIOCARBONATE

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase